Intrinsic Edge Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-300,000
Closed -$13.6M 182
2021
Q4
$13.6M Buy
+300,000
New +$15.7M 0.87% 33

Other funds holding CDNA

Intrinsic Edge Capital Management's CDNA Position: Q1 2025 in Review

Intrinsic Edge Capital Management sold out of CareDx (CDNA) in Q1 2025, closing a stake of 255,000 shares — an estimated $5.46M sold.

Intrinsic Edge Capital Management first reported a position in CDNA in Q1 2019 and held it in 14 quarters. The position peaked at $18.9M in Q2 2019. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Intrinsic Edge Capital Management reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 255,000 CareDx shares in Q1 2025, an estimated $5.46M.
  • Intrinsic Edge Capital Management first reported a position in CareDx in Q1 2019 and held it in 14 quarters.
  • Intrinsic Edge Capital Management's CareDx position peaked at $18.9M in Q2 2019.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2025, filed 12 May 2025.